Linaclotide 72 micrograms
Phase 3Small molecule
Linaclotide 72 micrograms is one of 5 small molecule programs targeting Chronic constipation. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Chronic Constipation
#DrugCompanyPhaseTrials
1Resotran
TakedaApproved
Golytely
BayerApproved
Linaclotide 72 micrograms
MMd Mehedi Shahriar
Phase 3
Ornidazole
AAssistance Publique - Hôpitaux de Paris
Preclinical
Phage
OOttawa Hospital Research Institute
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Linaclotide 72 micrograms. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- MMd Mehedi Shahriar